首页> 外文期刊>Pediatric Research >RESPONSE TO A BOOSTER DOSE OF H.influenzae TYPE B CAPSULAR POLYSACCHARIDE - DIPHTERIA TOXOID CONJUGATE VACCINE (PRP-D) IN CHILDREN INITIALLY IMMUNIZED AT 3- 5-7 OR ONLY 7 MONTHS
【24h】

RESPONSE TO A BOOSTER DOSE OF H.influenzae TYPE B CAPSULAR POLYSACCHARIDE - DIPHTERIA TOXOID CONJUGATE VACCINE (PRP-D) IN CHILDREN INITIALLY IMMUNIZED AT 3- 5-7 OR ONLY 7 MONTHS

机译:最初在3到5到7个月或仅在7个月内未接种疫苗的儿童对H型流感嗜血杆菌B型囊状多糖-白喉类毒素共轭疫苗(PRP-D)加强剂量的反应

获取原文
           

摘要

22 three months old children received three doses of PRP-D at 2 months intervals, and 21 only one dose when 7 months old. In both groups half of the children received booster immunization at 14 months, and the other half at 18 months. Sera were obtained prior and post immunizations and anti-PRP antibody levels were measured by Farr-type RIA. The vaccine was well tolerated; only mild reactions were noted. The antibody responses to initial immunization have already been published (Lancet, 1985): The third dose at 7 months resulted in high antibody levels, whereas only one dose at 7 months did not. The geometric mean (GM) antibody levels before booster immunization at 14 months were 1.02 ug/ml in children who had received 3 doses of PRP-D and 0.22 ug/ml when only 1 dose had been given.The post booster levels (GM) were 40.41, 43.56, 25.41 and 37.21 ug/ml in the four groups. All groups differed significantly from any group of children of the same age immunized with PRP only (GM levels below 1 ug/ml).In conclusion. A PRP-D booster given at 14 or 18 months to children who were previously immunized at 3-5-7 or only 7 months was well tolerated and resulted in significantly higher antibody levels than immunization by PRP alone does. This suggests that PRP-D can induce a real booster effect.
机译:22个3个月大的孩子每2个月间隔接受3剂PRP-D,而21个7个月大的孩子仅接受1剂。两组中的一半儿童在14个月接受加强免疫,另一半在18个月接受免疫。在免疫之前和之后获得血清,并通过Farr型RIA测量抗PRP抗体水平。疫苗耐受性良好。仅注意到轻微反应。抗体对初次免疫的反应已经公开(Lancet,1985):7个月的第三次剂量导致高抗体水平,而7个月的一次剂量没有。接受3剂PRP-D的儿童在14个月加强免疫前的几何平均(GM)抗体水平为1.02 ug / ml,仅给予1剂儿童为0.22 ug / ml。四组分别为40.41、43.56、25.41和37.21 ug / ml。所有组与仅使用PRP免疫的相同年龄的任何儿童组(GM水平低于1 ug / ml)都有显着差异。先前在3-5-7或仅7个月接受免疫的儿童在14或18个月接受PRP-D加强免疫的耐受性良好,抗体水平明显高于单独进行PRP免疫。这表明PRP-D可以诱导真正的增强作用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号